Publications by authors named "Tim Kanters"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

833

Total Likes

137

Extended Reach

361,704

Social Features

33
E
Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study.
Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Isaac Corro Ramos, Saskia le Cessie, Matthijs Versteegh, Job van Exel

Neurology· March 2024

Videos about Article: user user

2 31 2 16

View All Article and Social Media Activity
T
The Cost-Effectiveness of Seizure Dogs for Persons Living With Severe Refractory Epilepsy: Results From the EPISODE Study.
Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch

Value Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.
Antonis Valachis, Laura Biganzoli, Athina Christopoulou, Kamilla Fjermeros, Elena Fountzila, Tim Kanters

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Including carer health-related quality of life in NICE health technology assessments in the United Kingdom.
Tim A Kanters, Valérie van Hezik-Wester, Andy Boateng, Holly Cranmer, Ingelin Kvamme

Health Econ Policy Law· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of a digital health technology for older nursing home residents. A de-novo cost-effectiveness model for digital health technologies to aid in the assessment of toileting and containment care needs.
Katharina Abraham, Tim Andre Kanters, Adrian Stuart Wagg, Nicole Huige, Edward Hutt

PLoS One· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Disease Burden and Societal Costs of Hereditary Angioedema.
Lauré M Fijen, Philip C G Klein, Danny M Cohn, Tim A Kanters

J Allergy Clin Immunol Pract· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver Burden and Quality of Life Across Alzheimer's Disease Severity Stages.
Valérie J van Hezik-Wester, Ron L H Handels, Claire A G Wolfs, Tim A Kanters

Alzheimer Dis Assoc Disord· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study.
Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Matthijs Versteegh, Louis Wagner

Front Neurol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of Persons with Dementia Living in Nursing Homes in The Netherlands.
Philip Charles Gerard Klein, Simone Huygens, Ron Handels, Valérie Wester, Tim Andre Kanters

J Alzheimers Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Splenic Artery Embolization versus Splenectomy after Trauma in the Netherlands.
Tim A Kanters, Claudia P A M Raaijmakers, Paul N M Lohle, Jolanda de Vries, Leona Hakkaart-van Roijen

J Vasc Interv Radiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic.
Samare P I Huls, Ayesha Sajjad, Tim A Kanters, Leona Hakkaart-van Roijen, Werner B F Brouwer

Pharmacoeconomics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era.
Werner Brouwer, Samare Huls, Ayesha Sajjad, Tim Kanters, Leona Hakkaart-van Roijen

Pharmacoeconomics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy.
Valérie Wester, Saskia de Groot, Matthijs Versteegh, Tim Kanters, Louis Wagner

Value Health· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision.
Simone A Huygens, Matthijs M Versteegh, Stefan Vegter, L Jan Schouten, Tim A Kanters

Pharmacoeconomics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Providing Informal Care for Patients with Atrial Fibrillation.
Tim A Kanters, Jasper J Brugts, Olivier C Manintveld, Matthijs M Versteegh

Value Health· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab.
Margreet Franken, Tim Kanters, Jules Coenen, Paul de Jong, Agnes Jager

Breast· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE).
Valérie Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch

Front Neurol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Costs Using the Treatment Inventory Cost in Psychiatric Patients (TIC-P), TIC-P Mini and TIC-P Midi.
Tim A Kanters, Reinier Timman, Moniek C Zijlstra-Vlasveld, Anna Muntingh, Klaas M Huijbregts

J Ment Health Policy Econ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands.
Margreet G Franken, Tim A Kanters, Jules L Coenen, Paul de Jong, Harry R Koene

Anticancer Drugs· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care-related Quality of Life of informal caregivers of the elderly after a hip fracture.
Cornelis L P van de Ree, Kari Ploegsma, Tim A Kanters, Jan A Roukema, Mariska A C De Jongh

J Patient Rep Outcomes· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.
Catharina M Mulders-Manders, Tim A Kanters, Paul L A van Daele, Esther Hoppenreijs, G Elizabeth Legger

Orphanet J Rare Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
Saskia de Groot, Catherine F Enters-Weijnen, Petronella H Geelhoed-Duijvestijn, Tim A Kanters

BMJ Open· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease.
Tim A Kanters, Ans T van der Ploeg, Michelle E Kruijshaar, Dimitris Rizopoulos, W Ken Redekop

Orphanet J Rare Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update of the Dutch manual for costing studies in health care.
Tim A Kanters, Clazien A M Bouwmans, Naomi van der Linden, Siok Swan Tan, Leona Hakkaart-van Roijen

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel.
Tim A Kanters, Jelena Stevanovic, Isabelle Huys, Arnold G Vulto, Steven Simoens

Front Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis